Tumor markers used in diagnosis and monitoring of primary bronchopulmonary carcinoma
B Mahler - Pneumologia (Bucharest, Romania), 2008 - europepmc.org
Pneumologia (Bucharest, Romania), 2008•europepmc.org
Pulmonary neoplasm is a serious disease, often detected in its final stages. Tumor markers,
although not a diagnosis method for pulmonary neoplasms, are useful in monitoring the
response to treatment and the relapses, as follows: neuron specific enolase (NSE) increases
in micro-cellular neoplasm, Cyfra 21-1 increases in non-micro-cellular neoplasm, while the
increase of carcino-embryonic antigen (CEA) is non-specific, as it is high in both primary and
secondary lung cancer
although not a diagnosis method for pulmonary neoplasms, are useful in monitoring the
response to treatment and the relapses, as follows: neuron specific enolase (NSE) increases
in micro-cellular neoplasm, Cyfra 21-1 increases in non-micro-cellular neoplasm, while the
increase of carcino-embryonic antigen (CEA) is non-specific, as it is high in both primary and
secondary lung cancer
Pulmonary neoplasm is a serious disease, often detected in its final stages. Tumor markers, although not a diagnosis method for pulmonary neoplasms, are useful in monitoring the response to treatment and the relapses, as follows: neuron specific enolase (NSE) increases in micro-cellular neoplasm, Cyfra 21-1 increases in non-micro-cellular neoplasm, while the increase of carcino-embryonic antigen (CEA) is non-specific, as it is high in both primary and secondary lung cancer
europepmc.org